Psychemedics Recognized as a Top 10 Employee Health Testing Services Provider Psychemedics Corporation announces its recognition as one of the Top 10 Employee Health Testing Services Providers for 2024 by ManageHR

Unveiling the Future of Drug Testing: Psychemedics Introduces Advanced 5-Panel Drug Screen Psychemedics debuts a 5-panel drug test replacing marijuana with fentanyl, the first hair drug test exclusively targeting the most dire workplace threats.

Psychemedics Test for Fentanyl Detection Cleared by FDA ACTON, Mass., April 24, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world leader and pioneer in detecting drugs of abuse using hair analysis, today introduced the industry’s...